Michael Snyder, PhD Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. Dr. Snyder received his Ph.D. training at the California Institute of Technology and carried out postdoctoral training at Stanford University. He is a leader [...]
Atul Butte, MD, PhD Atul Butte, MD, PhD is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and inaugural Director of the Institute for Computational Health Sciences (ichs.ucsf.edu) at the University of California, San Francisco (UCSF). Dr. Butte is also the Chief Data Scientist for the entire University of [...]
Euan Ashley, MD, PhD Euan Ashley BSc (Hons), MB ChB, MRCP, DPhil, FACC, FAHA Associate Professor of Medicine (Cardiovascular), Director, Stanford Center for Inherited Cardiovascular Disease Co-Director, Training Program in Myocardial BiologyMember, Institute of Medicine Roundtable on Translating Genomic-based Research for Health Director, Stanford Cardiopulmonary Exercise Testing Laboratory Leadership [...]
Ken Ludlum Mr. Ludlum has served on our board of directors since July 2015. Mr. Ludlum also currently serves on the board of directors of NATUS Medical, Inc., a medical equipment company, IRIDEX Corporation, a medical device company and Dermavant Sciences Ltd, a biopharmaceutical company. From February 2014 to April [...]
Patrick J. Balthrop, Sr. Patrick J. Balthrop, Sr. is the founding principal of Apalachee Ventures. He has over 30 years of experience building, growing and optimizing businesses in the healthcare sector, particularly in the life sciences segments of diagnostics, life science tools and medical devices. Previously, Mr. Balthrop was [...]
Russ Altman, MD, PhD Russ Biagio Altman is Professor of Bioengineering, Genetics, & Medicine (and of Computer Science, by courtesy) and former Chairman of the Bioengineering Department at Stanford University. His primary research interests are in the application of computing technology to basic molecular biological problems of relevance to [...]
Carol J. Tillis Carol J. Tillis joined Personalis in November 2011 with over 20 years of experience in senior financial management, much of it related to DNA sequencing. From 2004 to 2010, she was Vice President of Finance at Pacific Biosciences, Inc. Ms. Tillis started at Pacific Biosciences as [...]
Jonathan MacQuitty, PhD Dr. MacQuitty, our Chairman of the Board, has served on our board of directors since June 2011. Since July 2018, Dr. MacQuitty has served on the board of directors of and as Chief Executive Officer of D2G Oncology, Inc., an oncology biotechnology company. Since April 2016, Dr. MacQuitty has [...]
Christian Haudenschild, PhD Dr. Haudenschild joined Personalis in early 2012 to build the company’s professional services department. Prior to this role he was an Associate Director in charge of commercial sequencing at Illumina Inc. in Hayward, California. His team was responsible for the preparation and next-generation sequencing of thousands of DNA [...]
Richard Chen, MD, MS Dr. Chen joined Personalis in November 2011 as Chief Scientific Officer, and was promoted to Senior Vice President R&D, and Chief Medical Officer in 2021. A physician scientist, Dr. Chen has extensive expertise in systems biology, translational genomics, knowledge engineering, and scientific product development. Dr. Chen [...]
